Hedgehog-Gli Signaling Pathway Inhibitors as Anticancer Agents

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTHedgehog-Gli Signaling Pathway Inhibitors as Anticancer AgentsNeeraj Mahindroo*, Chandanamali Punchihewa, and Naoaki FujiiView Author Information Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis 38105, Tennessee* To whom correspondence should be addressed. Phone: (+1) 901 595 5871. Fax: (+1) 901 595 5715. E-mail: [email protected]Cite this: J. Med. Chem. 2009, 52, 13, 3829–3845Publication Date (Web):March 23, 2009Publication History Received10 November 2008Published online23 March 2009Published inissue 9 July 2009https://pubs.acs.org/doi/10.1021/jm801420yhttps://doi.org/10.1021/jm801420yreview-articleACS PublicationsCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views5650Altmetric-Citations127LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Cancer,Cell signaling,Cells,Genetics,Inhibitors Get e-Alerts